Your browser doesn't support javascript.
loading
Spironolactone Reduces Aortic Stiffness in Patients With Resistant Hypertension Independent of Blood Pressure Change.
Aryal, Sudeep R; Siddiqui, Mohammed; Sharifov, Oleg F; Coffin, Megan D; Zhang, Bin; Gaddam, Krishna K; Gupta, Himanshu; Denney, Thomas S; Dell'Italia, Louis J; Oparil, Suzanne; Calhoun, David A; Lloyd, Steven G.
Afiliación
  • Aryal SR; Division of Cardiovascular Disease University of Alabama at Birmingham Birmingham AL.
  • Siddiqui M; Vascular Biology and Hypertension Program University of Alabama at Birmingham Birmingham AL.
  • Sharifov OF; Division of Cardiovascular Disease University of Alabama at Birmingham Birmingham AL.
  • Coffin MD; School of Medicine University of Alabama at Birmingham Birmingham AL.
  • Zhang B; Division of Biostatistics and Epidemiology Cincinnati Children's Hospital Medical Center Cincinnati OH.
  • Gaddam KK; Department of Pediatrics University of Cincinnati College of Medicine Cincinnati OH.
  • Gupta H; Division of Cardiovascular Disease University of Alabama at Birmingham Birmingham AL.
  • Denney TS; Valley Medical Group Paramus NJ.
  • Dell'Italia LJ; Department of Electrical and Computer Engineering Auburn University Auburn AL.
  • Oparil S; Division of Cardiovascular Disease University of Alabama at Birmingham Birmingham AL.
  • Calhoun DA; VA Medical Center Birmingham AL.
  • Lloyd SG; Division of Cardiovascular Disease University of Alabama at Birmingham Birmingham AL.
J Am Heart Assoc ; 10(17): e019434, 2021 09 07.
Article en En | MEDLINE | ID: mdl-34459249

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Espironolactona / Rigidez Vascular / Hipertensión / Antihipertensivos Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Am Heart Assoc Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Espironolactona / Rigidez Vascular / Hipertensión / Antihipertensivos Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Am Heart Assoc Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido